Bacitracin is commonly used in metabolic studies as an insulinase inhibitor. The many isoforms of the commercial preparation were fractionated by charge and size in order to find the most active rat-muscle insulinase inhibitors. CM-Sepharose chromatography revealed that most of the inhibitory activity was contained in a fraction (CM-Inh) that amounted to less than 5% of the mixture. The CM-Inh fraction could be further separated by size on Bio-Gel P4 columns. Six subgroups, each with characteristic specific activity, were isolated. The most potent inhibitor fractions have no antibiotic activity and have molecular weights about twice that of bacitracin A. The peaks isolated by means of Bio-Gel P4 chromatography can be further fractionated by reversed phase HPLC on a C8 column, and by electrophoresis on nonreducing acrylamide gels.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1006/bmmb.1993.1027 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tyrosine modifications of insulin-degrading enzyme enable favorable control of substrate specificity for both Alzheimer's disease and type-2 diabetes mellitus.
Bioorg Chem
December 2024
Department of Bio-Analytical Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-Ku, Sendai 980-8578, Japan. Electronic address:
Insulin-degrading enzyme (IDE) cleaves amyloid beta (Aβ), insulin, and other bioactive peptides. Because Aβ and insulin are closely related to Alzheimer's disease (AD) and type-2 diabetes mellitus (T2DM), respectively, IDE is a candidate drug target for treating both AD and T2DM. However, the activity of IDE has opposing effects, including decreasing AD risk by degrading Aβ and increasing T2DM risk by degrading insulin.
View Article and Find Full Text PDFInvestigation on synthesized sulfonamide Schiff base with DFT approaches and in silico pharmacokinetic studies: Topological, NBO, and NLO analyses.
Heliyon
July 2024
Department of Chemistry, Rajshahi University of Engineering & Technology, 6204, Bangladesh.
Article Synopsis
- - The study focuses on the successful synthesis and analysis of a sulfonamide Schiff base (CHNOS), employing both experimental methods and Density Functional Theory (DFT) to explore its molecular geometry and drug-like properties related to its potential as an insulysin inhibitor.
- - Experimental techniques such as FT-IR, UV-Vis, and H NMR were compared with simulated data from the DFT studies, confirming the compound's formation and stability, along with notable interactions that suggest its high chemical reactivity.
- - The compound adheres to key medicinal guidelines and exhibits a favorable ADMET profile, positioning it as a promising non-toxic oral drug candidate, while also demonstrating strong insulysin inhibition and enhanced non-linear optical properties compared
Synthesis, quantum chemical calculations, in silico and in vitro bioactivity of a sulfonamide-Schiff base derivative.
Heliyon
July 2024
Department of Chemistry, Rajshahi University of Engineering & Technology, 6204, Bangladesh.
The sulfonamide Schiff base compound (E)-4-((4-(dimethylamino)benzylidene)amino)-N-(5-methylisoxazol-3-yl)benzenesulfonamide was successfully prepared and fully characterized. The foremost objective of this study was to explore the molecular geometry of the aforementioned compound and determine its drug likeness characteristics, docking ability as an insulysin inhibitor, anticancer and antioxidant activities. The molecular structure of this compound was optimized using the B3LYP/6-311G+(d,p) level of theory.
View Article and Find Full Text PDFExpression and biochemical characterization of the putative insulinase enzyme PF11_0189 found in the Plasmodium falciparum genome.
Protein Expr Purif
October 2024
Department of Biotechnology, National Institute of Technology, Arunachal Pradesh, India.
PF11_0189 is a putative insulin degrading enzyme present in Plasmodium falciparum genome. The catalytic domain of PF11_0189 is about 27 kDa. Substrate specificity study shows PF11_0189 acts upon different types of proteins.
View Article and Find Full Text PDFInsulin-degrading enzyme inhibition increases the unfolded protein response and favours lipid accumulation in the liver.
Br J Pharmacol
October 2024
Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France.
Background And Purpose: Nonalcoholic fatty liver disease refers to liver pathologies, ranging from steatosis to steatohepatitis, with fibrosis ultimately leading to cirrhosis and hepatocellular carcinoma. Although several mechanisms have been suggested, including insulin resistance, oxidative stress, and inflammation, its pathophysiology remains imperfectly understood. Over the last decade, a dysfunctional unfolded protein response (UPR) triggered by endoplasmic reticulum (ER) stress emerged as one of the multiple driving factors.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!